Clinical prescribing (and off-label use) in a second-best world
- PMID: 20195172
- DOI: 10.1097/MLR.0b013e3181d60408
Clinical prescribing (and off-label use) in a second-best world
Comment on
-
The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.Med Care. 2010 Apr;48(4):372-9. doi: 10.1097/MLR.0b013e3181ca404e. Med Care. 2010. PMID: 20195173 Free PMC article.
Similar articles
-
'Off-label' prescribing, the Physician's Desk Reference and the court.J La State Med Soc. 2011 Sep-Oct;163(5):276-80. J La State Med Soc. 2011. PMID: 22272550
-
Health care policy. Reforming off-label promotion to enhance orphan disease treatment.Science. 2010 Jan 15;327(5963):273-4. doi: 10.1126/science.1181567. Science. 2010. PMID: 20075234 No abstract available.
-
Off-label use of drugs in children.Pediatrics. 2014 Mar;133(3):563-7. doi: 10.1542/peds.2013-4060. Epub 2014 Feb 24. Pediatrics. 2014. PMID: 24567009 Review.
-
Off-label use of drugs and medical devices: a review of policy implications.Clin Pharmacol Ther. 2012 May;91(5):920-5. doi: 10.1038/clpt.2012.22. Clin Pharmacol Ther. 2012. PMID: 22472990 No abstract available.
-
Promotion of Drugs for Off-label Uses: The US Food and Drug Administration at a Crossroads.JAMA Intern Med. 2017 Feb 1;177(2):157-158. doi: 10.1001/jamainternmed.2016.7151. JAMA Intern Med. 2017. PMID: 27820607 Review. No abstract available.
Cited by
-
Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.Med Care. 2012 Jun;50(6):466-78. doi: 10.1097/MLR.0b013e318245a160. Med Care. 2012. PMID: 22266704 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources